Suppr超能文献

血库安全操作实践:标签错误的样本和管内错误的血液——122 个临床实验室的 Q-Probes 分析。

Blood bank safety practices: mislabeled samples and wrong blood in tube--a Q-Probes analysis of 122 clinical laboratories.

机构信息

Department of Pathology, University of Washington, Seattle, USA.

出版信息

Arch Pathol Lab Med. 2010 Aug;134(8):1108-15. doi: 10.5858/2009-0674-CP.1.

Abstract

CONTEXT

Although a rare occurrence, ABO incompatible transfusions can cause patient morbidity and mortality. Up to 20% of all mistransfusions are traced to patient misidentification and/or sample mislabeling errors that occur before a sample arrives in the laboratory. Laboratories play a significant role in preventing mistransfusion by identifying wrong blood in tube and rejecting mislabeled samples.

OBJECTIVES

To determine the rates of mislabeled samples and wrong blood in tube for samples submitted for ABO typing and to survey patient identification and sample labeling practices and sample acceptance policies for ABO typing samples across a variety of US institutions.

DESIGN

One hundred twenty-two institutions prospectively reviewed inpatient and outpatient samples submitted for ABO typing for 30 days. Labeling error rates were calculated for each participant and tested for associations with institutional demographic and practice variable information. Wrong-blood-in-tube rates were calculated for the 30-day period and for a retrospective 12-month period. A concurrent survey collected institution-specific sample labeling requirements and institutional policies regarding the fate of mislabeled samples.

RESULTS

For all institutions combined, the aggregate mislabeled sample rate was 1.12%. The annual and 30-day wrong-blood-in-tube aggregate rates were both 0.04%. Patient first name, last name, and unique identification number were required on the sample by more than 90% of participating institutions; however, other requirements varied more widely.

CONCLUSIONS

The rates of mislabeled samples and wrong blood in tube for US participants in this study were comparable to those reported for most European countries. The survey of patient identification and sample labeling practices and sample acceptance policies for ABO typing samples revealed both practice uniformity and variability as well as significant opportunity for improvement.

摘要

背景

尽管这种情况很少见,但 ABO 血型不合输血可能会导致患者发病和死亡。多达 20%的输血错误可追溯到患者身份识别和/或样本标记错误,这些错误发生在样本到达实验室之前。实验室在识别试管中的错误血液和拒收标记错误的样本方面发挥着重要作用,可防止输血错误。

目的

确定提交进行 ABO 定型的样本中标记错误和试管内错误血液的比例,并调查美国各机构 ABO 定型样本的患者身份识别和样本标记实践以及样本接受政策。

设计

122 家机构前瞻性地审查了 30 天内提交进行 ABO 定型的住院和门诊样本。为每位参与者计算标记错误率,并测试其与机构人口统计学和实践变量信息的关联。计算了 30 天期间和回顾性 12 个月期间的试管内错误血液比例。同时进行的调查收集了特定机构的样本标记要求和关于标记错误样本处理的机构政策。

结果

所有机构的总标记错误样本率为 1.12%。年度和 30 天的试管内错误血液总比例均为 0.04%。超过 90%的参与机构要求在样本上注明患者的名字、姓氏和唯一识别号码;但是,其他要求则差异更大。

结论

在这项研究中,美国参与者的标记错误样本和试管内错误血液比例与大多数欧洲国家报告的比例相当。对 ABO 定型样本的患者身份识别和样本标记实践以及样本接受政策的调查显示出实践的一致性和变异性,以及显著的改进机会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验